Skip to main content

Pyrosequencing Will Distribute Corbett Products in US

NEW YORK, Jan. 14-Pyrosequencing has struck a distribution deal with Corbett Research, the company said yesterday.


Under the deal, Pyrosequencing will distribute Corbett's thermocycling and sample preparation products in the United States, including the four-channel thermocycler Rotor-Gene 3000, the PCR workstation CAS 1200, and other products.


Pyrosequencing will also make an equity investment in Bio-Molecular Holdings, which is the parent company of Corbett Research. The companies did not provide financial details, except to say that Pyrosequencing will own less than 20 percent of Bio-Molecular Holdings, and will have an option to purchase a further stake within the next three years.


Bio-Molecular Holdings is an Australian holding company for Corbett Research and Corbett Robotics.


Pyrosequencing, based in Uppsala, Sweden, manufactures and sells equipment for sequencing, pharmacogenomics and genotyping.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.